Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT02854592

Completed

Intravenous Thrombolysis Registry for Chinese Ischemic Stroke Within 4.5 h Onset (INTRECIS)

Ischemic Stroke
NCT01094977

Suspended

Blood Loss and Transfusion Requirement in Infants Treated With Tranexamic Acid

Craniosynostoses
NCT03973138

Unknown

Visual Outcomes and the Predictive Factors in Chinese Patients With Diabetic Macular Edema Treated With Ranibizumab (IVRDME)

Diabetic Macular Edema
NCT00355108

Completed

ATERO : A Randomised Study With Tranexamic Acid in Epistaxis of Rendu Osler Syndrome

Telangiectasia, Hereditary Hemorrhagic | Osler-Rendu Disease
NCT02161575

Completed

Safety and Efficacy of Switching From Aflibercept to Ranibizumab in Patients With nAMD (SAFARI)

Neovascular Age-related Macular Degeneration
NCT03370380

Completed

Aflibercept in Patients With Pigment Epithelial Detachments (PED)

Pigment Epithelial Detachment
NCT03595085

Unknown

Catheter Directed Interventions in Pulmonary Embolism

Pulmonary Embolism
NCT02644473

Withdrawn

Safety of Topical Tranexamic Acid in Total Joint Arthroplasty in High Risk Patients

Myocardial Infarction | Stroke | Deep Vein Thrombosis | Pulmonary Embolism
NCT02002377

Terminated

Intravitreal Aflibercept in Wet Age Related Macular Degeneration Patients With an Incomplete Response to Routine Ranibizumab Injections (SHIFT-2)

Age Related Macular Degeneration
NCT00685854

Completed

Ranibizumab Injections to Treat Macular Telangiectasia Without New Blood Vessel Growth

Macular Telangiectasia
NCT00457145

Completed

Injected Ranibizumab to Treat Macular Telangiectasia Without New Blood Vessel Formation

Telangiectasia
NCT00457067

Completed

Injected Ranibizumab to Treat Macular Telangiectasia With New Blood Vessel Formation

Telangiectasia
NCT01940536

Withdrawn

The Effect of Tranexamic Acid on Transfusion Rates in Intertrochanteric Hip Fractures

Blood Loss | Hip Fracture
NCT01315275

Completed

A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular Edema (LUDIC)

Macular Edema | Visual Impairment
NCT01204333

Terminated

Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis (TOACT)

Sinus Thrombosis, Intracranial
NCT01169909

Completed

Efficacy and Safety of Sub-tenon Ranibizumab for Recurrent Pterygia

Pterygium
NCT01356329

Suspended

Efficacy and Safety of the LovenoxTM (Enoxaparin) Versus HeparinTM Gynecologic Oncology Patients (Lovenox)

Malignant Female Reproductive System Neoplasm
NCT00805116

Terminated

Marine Oils and Arthritis

Rheumatoid Arthritis
NCT02738073

Unknown

Effects of Tranexamic Acid on Blood Loss and Transfusion Requirement Following Hip Fracture

Hip Fracture
NCT02688127

Completed

Efficacy of Tranexamic Acid In Reducing Blood Loss During Cesarean Section Because Of Placenta Previa

Postpartum Haemorrage Sever Bleeding After Delivery
NCT01687491

Completed

Comparison of Anti-Xa Activity of ENOXA ® Versus LOVENOX ® in Acute Coronary Syndrome (AXA)

Acute Coronary Syndrome | Factor X
NCT02372916

Unknown

Geographic Atrophy and Intravitreal Ranibizumab Injections

Age-related Macular Degeneration | Geographic Atrophy
NCT01881568

Completed

Efficacy Comparison of Topical and Intravenous Tranexamic Acid to Reduce the Number of Blood Transfusions in TKA (TRANEX1)

Blood Loss
NCT00263978

No longer available

Defibrotide Compassionate Use for Patients With Life Threatening Veno-Occlusive Disease of the Liver

Liver Diseases
NCT01447043

Completed

Study to Assess the Effectiveness of Existing Anti vascUlar Endothelial Growth Factor (Anti VEGF) in Patients With Wet Age-related Macular Degeneration (wAMD) (AURA) (AURA)

Ophthalmology, Macular Degeneration
NCT00238537

Completed

Echoplanar Imaging Thrombolysis Evaluation Trial (EPITHET)

Stroke
NCT00996684

Unknown

Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration (AMD)

Macular Degeneration
NCT00469352

Completed

A Study of Genetic and Environmental Factors and Their Effect on Response to Treatment With Lucentis (Ranibizumab) for Wet AMD

Macular Degeneration
NCT00004875

Completed

Heparin or Enoxaparin in Patients With Cancer

Lymphoma | Unspecified Adult Solid Tumor, Protocol Specific | Thromboembolism
NCT00077805

Completed

PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)

Acute Ischemic Stroke
NCT07107659

Recruiting

Safety and Efficacy of ONT01 in Lupus

Systemic Lupus Erythematosus | SLE | Lupus | Lupus Nephritis (LN) | Systemic Lupus Erythematosus (Disorder) | Lupus Nephritis - World Health Organization (WHO) Class III | Lupus Nephritis - WHO Class IV | Lupus Nephritis - WHO Class III
NCT05650476

Available

Pre-approval Single-patient Expanded Access for Talazoparib (PF-06944076)

Metastatic Castration-Resistant Prostate Cancer
NCT05097365

Enrolling by invitation

Methyl-donor Nutrient Supplementation and Methylation Profile in Lupus Patients With Obesity

Overweight and Obesity | Lupus Erythematosus
NCT03262207

Unknown

Epigenetic Integrity of Spermatozoa in Patients With Germinal Testicular Tumours (GAMETH)

Seminomas
NCT01470807

Completed

Pilot Study 1 of Outpatient Control-to-Range - System and Monitoring Testing

Type 1 Diabetes Mellitus
NCT07593352

Recruiting

Renal Dysfunction in Patients With Inflammatory Bowel Disease and the General Population (NEPHRO-IBD) (NEPHRO-IBD)

Chronic Kidney Disease | Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis) | IBD and Renal Involement
NCT03941535

Recruiting

Comparison of Vitamin K Doses in Patients With Larger Burn Injuries (VITK)

Burns
NCT05662410

Completed

Choroidal Morphology Changes After Aflibercept Therapy in Pachychoroid Neovasculopathy

Pachychoroid Neovasculopathy
NCT00533962

Unknown

IOP Reduction After Anecortave Acetate Injection in Glaucoma Patients

Glaucoma | Intraocular Pressure
NCT07321665

Recruiting

Effects of Physical Activity and Fitness, Cardiovascular- and Psychosocial Health on Medically Assisted Reproduction (REPRO-FIT)

Infertility, Female
NCT05400252

Active, not recruiting

Whole Health in VA Mental Health: Omnis Salutis (OS RCT)

Substance-Related Disorders | Depressive Disorder | Anxiety Disorders | Stress Disorders, Post-Traumatic
NCT02656693

Completed

Integrating Online Weight Management With Primary Care Support (PROPS)

Obesity
NCT04719065

Active, not recruiting

A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Solid Tumor

Advanced Solid Tumor
NCT00315679

Completed

A Trial of Pentoxifylline for the Treatment of Recurrent Aphthous Stomatitis

Recurrent Aphthous Stomatitis
NCT00827931

Completed

Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery

Gastrectomy | Colectomy | Pancreaticoduodenectomy | Esophagectomy | Biliary Tract Surgical Procedures
NCT06960616

Recruiting

Improving Clinical Efficiency by Reducing Scheduled Follow-ups Using Cochlear America's Population Mean Mapping Strategy

Deafness | Cochlear Hearing Loss
NCT06616857

Recruiting

Personalized Mobile Health Platform to Promote Physical Activity in Adolescents and Young Adults With Cystic Fibrosis (NUDGE)

Cystic Fibrosis (CF)
NCT06549985

Recruiting

Interdisciplinary Group Care for the Treatment of Endometriosis-associated Pain (PEEPS RCT)

Endometriosis | Pelvic Pain
NCT06538636

Not yet recruiting

Prediction Augmented Screening Initiative (PASI)

Lung Cancer | Lung Cancer Screening
NCT06630676

Completed

The Ability of Chronic Pain Patients to Self-diagnose Their Chief Source of Low Back Pain

Chronic Low Back Pain

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations